Showing results (11-20 of 1,020) with videos related to
Sort By:
Pageof 102
British Journal of Clinical Pharmacology|July 1, 1987
Thymoxamine: lack of antihistaminic effects in clinical doses in manS Al-Damluji, A Grossman, P Turner, et al.Journal of Molecular Endocrinology|August 1, 1991
Involvement of calmodulin in depolarization-induced release of corticotrophin-releasing hormone-41 from the rat hypothalamus in vitroS Tsagarakis, L H Rees, G M Besser, et al.Journal of Neuroendocrinology|February 13, 2009
Gamma-Aminobutyric Acid Modulation of Corticotrophin-Releasing Factor-41 Secretion from the Rat Hypothalamus in vitroS Tsagarakis, L H Rees, G M Besser, et al.Clinical Endocrinology|February 1, 1986
Depot-bromocriptine treatment for prolactinomas and acromegalyA Grossman, R Ross, J A Wass, et al.Brain Research|November 13, 1989
Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitroS Tsagarakis, L H Rees, G M Besser, et al.Clinical Endocrinology|January 1, 1985
Evidence for the participation of endogenous opioids in the sympathoadrenal response to hypoglycaemia in manP M Bouloux, A Grossman, N Lytras, et al.Neuroendocrinology|February 1, 1983
Dopaminergic control of the rat thyrotrophJ Price, A Grossman, G M Besser, et al.Acta Endocrinologica. Supplementum|January 1, 1986
Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient childrenR J Ross, A Grossman, G M Besser, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|January 1, 1989
Dose-dependent effects of vasoactive intestinal polypeptide on somatostatin release from hypothalamic fragments in vitroA M Lengyel, A Grossman, L H Rees, et al.Lancet (London, England)|November 22, 1980
Inhibition of vasopressin release in man by an opiate peptideA Grossman, G M Besser, J J Milles, et al.Pageof 102